How Can We Increase Model Utility for Combination Therapy?
Time: 2:40 pm
day: Day Two
- How to select the right model to use? Is it a trial-and-error approach?
- What did we learn from our clinical studies, and incorporate this into our preclinical programs? E.g. toxicity & dosing schedule
- How to combat resistance mechanisms?